Juhi Ojha

1.0k total citations
15 papers, 539 citations indexed

About

Juhi Ojha is a scholar working on Molecular Biology, Genetics and Pathology and Forensic Medicine. According to data from OpenAlex, Juhi Ojha has authored 15 papers receiving a total of 539 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 4 papers in Genetics and 3 papers in Pathology and Forensic Medicine. Recurrent topics in Juhi Ojha's work include Chronic Lymphocytic Leukemia Research (3 papers), Lymphoma Diagnosis and Treatment (3 papers) and Glycosylation and Glycoproteins Research (2 papers). Juhi Ojha is often cited by papers focused on Chronic Lymphocytic Leukemia Research (3 papers), Lymphoma Diagnosis and Treatment (3 papers) and Glycosylation and Glycoproteins Research (2 papers). Juhi Ojha collaborates with scholars based in United States, United Kingdom and Germany. Juhi Ojha's co-authors include Anil G. Cashikar, Esteban Braggio, Rafaël Fonseca, David Dunlap, Gunasingh Masilamoni, Jackline de Paula Ayres-Silva, Jan B. Egan, A. Keith Stewart, Helen M. Hansen and Scott Van Wier and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and Blood.

In The Last Decade

Juhi Ojha

14 papers receiving 534 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Juhi Ojha United States 11 236 206 171 132 91 15 539
Kenji Wakiya Japan 10 229 1.0× 63 0.3× 84 0.5× 78 0.6× 18 0.2× 24 477
Kristin E. Hunt United States 7 240 1.0× 150 0.7× 52 0.3× 35 0.3× 43 0.5× 11 428
Gary McIntosh United Kingdom 8 191 0.8× 72 0.3× 75 0.4× 48 0.4× 41 0.5× 9 491
Maurizio Trubia Italy 16 303 1.3× 104 0.5× 79 0.5× 13 0.1× 41 0.5× 18 615
Ken-ichi Sawada Japan 9 214 0.9× 55 0.3× 81 0.5× 18 0.1× 75 0.8× 9 396
Amber C. Donahue United States 14 286 1.2× 86 0.4× 122 0.7× 13 0.1× 35 0.4× 22 583
Fazila Asmar Denmark 16 550 2.3× 146 0.7× 92 0.5× 27 0.2× 13 0.1× 22 763
Philip Caron United States 14 278 1.2× 101 0.5× 56 0.3× 44 0.3× 14 0.2× 34 666
Ilan Kolkowitz United States 6 164 0.7× 259 1.3× 62 0.4× 96 0.7× 13 0.1× 8 637
Billy Michael Chelliah Jebaraj Germany 10 117 0.5× 99 0.5× 173 1.0× 10 0.1× 56 0.6× 19 300

Countries citing papers authored by Juhi Ojha

Since Specialization
Citations

This map shows the geographic impact of Juhi Ojha's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Juhi Ojha with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Juhi Ojha more than expected).

Fields of papers citing papers by Juhi Ojha

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Juhi Ojha. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Juhi Ojha. The network helps show where Juhi Ojha may publish in the future.

Co-authorship network of co-authors of Juhi Ojha

This figure shows the co-authorship network connecting the top 25 collaborators of Juhi Ojha. A scholar is included among the top collaborators of Juhi Ojha based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Juhi Ojha. Juhi Ojha is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Paranjpe, Rutugandha, Chen Cai, Yezhou Sun, et al.. (2025). Molecular heterogeneity in dMMR/MSI-H endometrial cancer in the US.. Journal of Clinical Oncology. 43(16_suppl).
2.
Ojha, Juhi, et al.. (2020). Multiplexed clonality verification of cell lines for protein biologic production. Biotechnology Progress. 36(4). e2978–e2978. 5 indexed citations
3.
Wu, Paul Y K, Louise Almond, Jennitte Stevens, et al.. (2019). Advancing Biologics Development Programs with Legacy Cell Lines: Advantages and Limitations of Genetic Testing for Addressing Clonality Concerns Prior to Availability of Late Stage Process and Product Consistency Data. PDA Journal of Pharmaceutical Science and Technology. 74(2). 264–274. 2 indexed citations
4.
Wiemels, Joseph L., Kyle M. Walsh, Adam J. de Smith, et al.. (2018). GWAS in childhood acute lymphoblastic leukemia reveals novel genetic associations at chromosomes 17q12 and 8q24.21. Nature Communications. 9(1). 286–286. 71 indexed citations
5.
Ojha, Juhi, Iryna Dyagil, Stuart C. Finch, et al.. (2018). Genomic characterization of chronic lymphocytic leukemia (CLL) in radiation-exposed Chornobyl cleanup workers. Environmental Health. 17(1). 43–43. 11 indexed citations
6.
Kutiyanawalla, Ammar, Byung Rho Lee, Juhi Ojha, et al.. (2018). TIMP-1 downregulation modulates miR-125a-5p expression and triggers the apoptotic pathway. Oncotarget. 9(10). 8941–8956. 13 indexed citations
7.
Ojha, Juhi, Veryan Codd, Christopher P. Nelson, et al.. (2016). Genetic Variation Associated with Longer Telomere Length Increases Risk of Chronic Lymphocytic Leukemia. Cancer Epidemiology Biomarkers & Prevention. 25(7). 1043–1049. 50 indexed citations
8.
Barrio, Santiago, Tait D. Shanafelt, Juhi Ojha, et al.. (2016). Genomic characterization of high-count MBL cases indicates that early detection of driver mutations and subclonal expansion are predictors of adverse clinical outcome. Leukemia. 31(1). 170–176. 39 indexed citations
9.
Smith, Adam J. de, Juhi Ojha, Stephen Francis, et al.. (2016). Clonal and microclonal mutational heterogeneity in high hyperdiploid acute lymphoblastic leukemia. Oncotarget. 7(45). 72733–72745. 11 indexed citations
10.
Braggio, Esteban, Scott Van Wier, Juhi Ojha, et al.. (2015). Genome-Wide Analysis Uncovers Novel Recurrent Alterations in Primary Central Nervous System Lymphomas. Clinical Cancer Research. 21(17). 3986–3994. 150 indexed citations
11.
Kortüm, K. Martin, Christian Langer, Jorge Monge, et al.. (2015). Longitudinal analysis of 25 sequential sample-pairs using a custom multiple myeloma mutation sequencing panel (M3P). Annals of Hematology. 94(7). 1205–1211. 36 indexed citations
12.
Ojha, Juhi, Jackline de Paula Ayres-Silva, Charla Secreto, et al.. (2014). Deep sequencing identifies genetic heterogeneity and recurrent convergent evolution in chronic lymphocytic leukemia. Blood. 125(3). 492–498. 38 indexed citations
13.
Braggio, Esteban, Brian Patrick O’Neill, Scott Van Wier, et al.. (2013). The Genomic Landscape Of Primary Central Nervous System Lymphomas. Blood. 122(21). 504–504. 1 indexed citations
14.
Ojha, Juhi, et al.. (2011). Behavioral Defects in Chaperone-Deficient Alzheimer's Disease Model Mice. PLoS ONE. 6(2). e16550–e16550. 30 indexed citations
15.
Ojha, Juhi, et al.. (2011). Sequestration of Toxic Oligomers by HspB1 as a Cytoprotective Mechanism. Molecular and Cellular Biology. 31(15). 3146–3157. 82 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026